Thoratec’s stock drops more than 26% in after-hours trading after the company lowers its full-year guidance on a dreary 2nd quarter.
Circulatory devices maker Thoratec (NSDQ:THOR) took a major hit yesterday as a bleak 2nd-quarter reports and a lowered outlook on the year sent its stock into a nosedive.
Company leadership called the quarter “disappointing,” but advised that near-term headwinds would ebb and that the long-term outlook remains strong for Thoratec. Wall Street’s response wasn’t so optimistic.
Help employers find you! Check out all the jobs and post your resume.
